Phase 2 Thrombosis Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Renal Cell CarcinomaKidney CancerRenal Cancer+1 more
University of Colorado, Denver17 enrolled3 locationsNCT05969496
Recruiting
Phase 2
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
BevacizumabHepatecellular CarcinomaRALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin+3 more
Nanfang Hospital, Southern Medical University38 enrolled1 locationNCT07327788
Recruiting
Phase 2Phase 3
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
ThrombosisSuperficial Vein ThrombosisSVT
Ottawa Hospital Research Institute50 enrolled2 locationsNCT06965998
Recruiting
Phase 2
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
Thrombosis, Deep VeinIliofemoral; Thrombosis
Mercator MedSystems, Inc.80 enrolled17 locationsNCT04862468
Recruiting
Phase 2Phase 3
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Deep Venous Thrombosis
Yale University258 enrolled22 locationsNCT04924322
Recruiting
Phase 2
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
Hepatocellular CarcinomaPortal Vein Thrombosis
Samsung Medical Center63 enrolled1 locationNCT05625893
Recruiting
Phase 2
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06389422
Recruiting
Phase 2
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
Iliofemoral; Thrombosis
Mercator MedSystems, Inc.60 enrolled15 locationsNCT04858776
Recruiting
Phase 2
Anticoagulant therapy for cancer-associated blood clots
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
South East Sydney and Illawarra Area Health Service600 enrolled5 locationsACTRN12617000331336
Completed
Phase 2Phase 3
Potential of natural dietary antioxidants in improving heart health in obesity
ObesityThrombosis
CQUniversity46 enrolled1 locationACTRN12615000797572
Completed
Phase 2Phase 3
Randomized controlled trial of a new light weight battery operated calf compression device (Venowave) for prevention of venous thrombosis.
venous thrombosis prevention in neurosurgery
Hamilton Health Sciences150 enrolled1 locationACTRN12611000424909
Recruiting
Phase 2Phase 3
Central Lines: Outcomes of Thrombosis and Sepsis study
Central venous catheter related thrombosis
Women's and Children's Hospital100 enrolled1 locationACTRN12611000070932
Completed
Phase 2
Once-daily oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis. The Einstein-DVT dose-finding study.
Acute symptomatic deep-vein thrombosis
Bayer Australia Ltd520 enrolled1 locationACTRN12605000597695